×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学... [153]
中国医学科学院 北... [95]
上海药物研究所 [55]
合肥物质科学研究院 [27]
四川大学 [20]
吉林大学白求恩第一... [19]
更多...
内容类型
期刊论文 [393]
会议论文 [112]
其他 [2]
学位论文 [2]
发表日期
2022 [13]
2021 [19]
2020 [12]
2019 [60]
2018 [61]
2017 [74]
更多...
学科主题
Biochemist... [1]
Biochemist... [1]
Cell Biolo... [1]
Chemistry,... [1]
Immunology [1]
Materials ... [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共509条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
DATA-ADAPTIVE EFFICIENT ESTIMATION STRATEGIES FOR BIOMARKER STUDIES EMBEDDED IN RANDOMIZED TRIALS
期刊论文
ANNALS OF APPLIED STATISTICS, 2022, 卷号: 16, 期号: 4, 页码: 2250-2265
作者:
Zhang, Weiz
;
Zhang, Zhi wei
;
Troendle, James F.
;
Liu, Aiyi
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2023/02/07
Augmentation
precision medicine
semiparametric theory
super learner
two-phase sampling
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial
期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 18
作者:
Li, Ning
;
Zhu, Jianqing
;
Yin, Rutie
;
Wang, Jing
;
Pan, Lingya
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2022/12/23
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer
期刊论文
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 卷号: 14
作者:
Yan, Min
;
Yuan, Peng
;
Ouyang, Quchang
;
Cheng, Ying
;
Han, Guohui
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2022/12/23
breast cancer
chemotherapy
efficacy
lobaplatin
neoplasm metastasis
safety
Neoadjuvant immunotherapy in non-small-cell lung cancer: a narrative review on mechanisms, efficacy and safety
期刊论文
JOURNAL OF THORACIC DISEASE, 2022
作者:
Shao, Lan
;
Lou, Guangyuan
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2022/12/22
Neoadjuvant
immunotherapy
immune-checkpoint inhibitors
non-small cell lung cancer (NSCLC)
Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
期刊论文
PHARMACEUTICS, 2022, 卷号: 14
作者:
Ji, Qing
;
Wu, Yuchen
;
Albers, Andreas
;
Fang, Meiyu
;
Qian, Xu
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2022/12/22
oncolytic viruses
nanotechnology
oncolytic virotherapy
immunotherapy
melanoma
head and neck cancer
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Li, Ning
;
Zhang, Youzhong
;
Wang, Jing
;
Zhu, Jianqing
;
Wang, Li
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2022/12/22
Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis
期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11
作者:
Lei, Lei
;
Chen, Rucheng
;
Fan, Lei
;
Zheng, Weijun
;
Wang, Xiaojia
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2022/12/23
Breast cancer
nanoparticle-albumin-bound paclitaxel (Nab-P)
taxanes
meta-analysis
Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Sun, Yan
;
Hu, Chaosu
;
Lin, Qin
;
Gao, Li
;
Wang, Jianhua
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2022/12/23
Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Jin, Jing
;
Tang, Yuan
;
Hu, Chen
;
Jiang, Li-Ming
;
Jiang, Jun
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/12/23
Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial
期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022
作者:
Liu, Jihong
;
Yin, Rutie
;
Wu, Lingying
;
Zhu, Jianqing
;
Lou, Ge
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2022/05/05
BRCA mutation
China
olaparib
ovarian cancer
PARP inhibitor
©版权所有 ©2017 CSpace - Powered by
CSpace